钙片

Search documents
汤臣倍健的中年危机:攻不下直播间,守不住药店,失守于经销商
Hua Xia Shi Bao· 2025-09-04 13:49
Core Insights - In 2025, the company celebrates its 30th anniversary but faces significant challenges with declining revenue and net profit after a difficult 2024 [2] - The brand struggles to resonate with younger consumers, who prefer newer brands like Swisse, indicating a shift in market dynamics [3][4] - The company's marketing efforts have not translated into sales growth, with a notable increase in sales expenses without corresponding revenue increases [4][5] Financial Performance - In 2023, sales expenses reached 3.859 billion, a 21.77% increase year-on-year, while revenue growth was only 19.66%, indicating diminishing returns on marketing investments [4] - In the first half of 2025, sales expenses were 1.233 billion, down 32.33% from 1.822 billion, but revenue still declined by 23.43%, showing ongoing challenges in sales momentum [5] - The company reported a 62.62% drop in net profit in 2024, marking the most severe decline in years, with continued revenue decreases into 2025 [5][10] Marketing and Sales Strategy - The company has significantly cut marketing expenses, with advertising costs dropping over 50% in the first half of 2025, yet this has not led to improved sales performance [7][11] - Despite reducing costs, the sales expense ratio reached a historical high of 44.33% in 2024, indicating that marketing efficiency is declining [11] - The company has also reduced R&D expenses by 56.45% in the first half of 2025, which may impact long-term innovation and competitiveness [13] Market Position and Consumer Perception - The brand is losing its appeal among younger consumers, who view it as outdated compared to competitors [3][15] - The company has seen a significant decline in its dealer network, with the number of dealers dropping from 1,070 in 2021 to 640 in 2025 [17] - Revenue from key products like "健力多" has decreased significantly, with a drop from over 1 billion in 2022 to 411 million in the first half of 2025 [17] Challenges and Future Outlook - The company faces a dual challenge of declining sales and increasing competition from new brands and online platforms [14][18] - The traditional sales channels are under pressure, with both online and offline revenues declining significantly [16][18] - The future success of the company hinges on its ability to adapt to market changes, engage younger consumers, and innovate its product offerings [18]
钙片、胶囊、液体钙到底怎么选?一篇给你讲清楚,告别选择困难
Sou Hu Wang· 2025-08-26 11:13
Core Viewpoint - Calcium is essential for bone health, but many people's diets fail to meet the necessary intake due to high salt and selective eating habits. It is crucial for long-term low-calcium dieters, menopausal women, the elderly, and those with limited physical activity to adjust their diets and scientifically supplement calcium [1] Group 1: Common Misconceptions - Misconception 1: More calcium is better. Excessive calcium intake can lead to health risks, and recommended daily intake varies by age and physiological status, such as 800mg for children aged 4-10 and adults over 18, and 1000mg for teenagers aged 11-17 and seniors over 50 [2][3] - Misconception 2: The type of supplement determines absorption. The source of calcium is more critical than the form of the supplement. For example, calcium carbonate requires sufficient stomach acid for absorption, while calcium citrate is more easily absorbed [4][5] - Misconception 3: Only calcium supplementation is necessary. Calcium absorption is enhanced by other nutrients like Vitamin D, Vitamin K, and collagen, which should be taken together for optimal effectiveness [6][7][8] Group 2: Product Comparisons - Calcium Tablets: - Calcium Carbonate D3 Tablets contain 600mg of calcium carbonate and 125 IU of Vitamin D3, but may cause discomfort for those with low stomach acid [11] - Swisse Calcium Citrate Tablets contain 333mg of calcium citrate, 665 IU of Vitamin D, and 60μg of Vitamin K, with a high absorption rate and minimal gastrointestinal discomfort [14] - Calcium Capsules: - Tongrentang DK Capsules contain 500mg of calcium carbonate, 360 IU of Vitamin D, and 24μg of Vitamin K, but may cause constipation due to the calcium source [17] - Schiff Vitamin D and K Softgels contain 500mg of a dual calcium source and are easy to swallow, but may require additional supplementation of nutrients [20] - Liquid Calcium: - Mom's Garden Liquid Calcium contains 500mg of patented organic calcium and 400 IU of Vitamin D, with a high absorption rate and added collagen for joint support [23] - Golden Calcium Liquid contains 300mg of calcium citrate and additional nutrients to enhance absorption, but may require further supplementation [26] Group 3: Key Principles for Effective Calcium Supplementation - Choose the right type of calcium based on individual digestive sensitivity, preferring calcium citrate or natural biological calcium [27] - Ensure synergistic intake with Vitamin D and Vitamin K2 for better absorption and utilization [28] - Monitor dosage to avoid excessive intake, with a recommendation of ≤500mg per single dose and total daily intake [28] - Select supplements that are easy to take and fit personal preferences to ensure adherence [28] - Individualize choices based on specific health needs and consult medical professionals if diagnosed with osteoporosis [29]
汤臣倍健蒸发400亿:年轻人不怕老,不怕死,只怕穷?
凤凰网财经· 2025-08-20 12:27
Core Viewpoint - The health supplement market in China is experiencing significant challenges, as evidenced by the poor performance of leading companies like汤臣倍健, which has seen substantial declines in revenue and profit. However, the overall market is still growing, driven by younger consumers seeking health products, indicating a shift in consumer behavior and preferences [3][4][32]. Group 1: Company Performance -汤臣倍健 reported a revenue of 35.32 billion yuan in the first half of 2025, a year-on-year decline of 23.43%, with a net profit of 7.37 billion yuan, down 17.34% [3]. - For the entire year of 2024,汤臣倍健's revenue was 68.38 billion yuan, a decrease of 27.3%, and net profit fell by 62.62%, marking the largest decline since its listing [3][9]. - The company's market capitalization has dropped from a peak of 600 billion yuan to approximately 209 billion yuan, resulting in a loss of nearly 400 billion yuan in value [3][9]. Group 2: Market Trends - The health supplement industry is not in decline; rather, it is evolving, with younger consumers engaging in "punk health" practices, leading to increased spending on health products [5][14]. - Data from 2023 indicates a 255% increase in consumption of uric acid monitoring products among consumers born in the 1990s, with 30% of their spending on immune-boosting supplements [15]. - Brands targeting younger demographics, such as诺特兰德 and Swisse, are thriving by employing innovative marketing strategies and product offerings [16][19]. Group 3: Challenges and Strategies -汤臣倍健's traditional marketing and distribution strategies have become outdated, leading to a significant drop in sales across its product lines [10][11]. - The company has reduced its advertising and marketing expenses, which has further contributed to declining revenues and profits [11]. - Despite launching new products,汤臣倍健 has struggled to capture the younger market, missing out on the e-commerce boom and innovative marketing tactics that competitors have successfully utilized [12][17]. Group 4: Historical Context - The Chinese health supplement market has evolved over nearly 40 years, with discussions around "intelligence tax" continuing as long as consumers fear aging, death, and loss of beauty [21][32]. - The market saw significant growth in the 1990s, but regulatory changes led to a downturn, from which汤臣倍健 and other second-generation companies emerged to dominate the market [31][32]. - Recent data shows that the health supplement market generated sales of 604.1 billion yuan in the first half of 2025, reflecting a growth of 16.2%, with specific categories like sleep management products growing by 53.1% [32].
零售药店倒闭潮来了?去年关了3.9万家
Qi Lu Wan Bao Wang· 2025-08-11 00:28
Core Insights - The retail pharmacy industry in China is experiencing a significant downturn, with an estimated 39,000 pharmacies expected to close in 2024, averaging 107 closures per day, and projections suggesting that closures could exceed 100,000 by 2025 [1][2] - Major players in the industry, such as Guoda Pharmacy and Jianzhijia, have reported substantial losses, with Guoda closing over 1,270 stores and incurring a net loss of over 1.1 billion yuan in 2024 [2] - The rapid expansion of pharmacies from 524,000 in 2019 to 667,000 in 2023 has led to market saturation, with the average number of customers served per store dropping from 4,112 in 2016 to 2,113 in 2023 [2][3] Industry Challenges - The high density of pharmacies has resulted in aggressive price competition, with many stores resorting to loss-leader pricing strategies to attract customers, ultimately harming their profitability [3] - Changing consumer habits, particularly among younger generations who prefer online channels for purchasing medications, have further exacerbated the decline in foot traffic to physical stores [3] - Tightening healthcare policies, including stricter regulations on insurance reimbursements and the shift of chronic disease medication distribution from pharmacies to community hospitals, have significantly impacted pharmacy revenues [3][4] Regulatory Environment - Starting in 2025, all participating pharmacies must implement drug traceability codes, complicating the procurement and settlement processes, which could increase operational costs for smaller pharmacies [4][5] - The requirement for licensed pharmacists to be present in all pharmacies by December 31, 2025, adds further compliance pressure, particularly for smaller operations [5] - The transition from a rapid expansion phase to a necessary industry adjustment reflects the need for pharmacies to focus on their role in public health rather than profit maximization [5]
3亿老龄人口撑起的万亿食养市场,还有这些短板亟待解决
新消费智库· 2025-06-02 13:28
Core Viewpoint - The elderly food and nutrition market in China is poised to become a trillion-dollar industry, driven by the increasing aging population and their diverse needs for health and nutrition [1][4][6]. Group 1: Market Overview - The elderly population in China is projected to exceed 310 million by 2024, accounting for 22% of the total population, with those aged 65 and above reaching 220.23 million, or 15.6% [6]. - The silver economy is not limited to traditional elder care but encompasses a vast industry that includes various sectors such as nutrition, health management, and community services [4][6]. - The market for elderly food and nutrition is expected to reach 9 trillion yuan by 2025, with the food and health-related sectors accounting for approximately 23.5% of this market [13]. Group 2: Consumer Needs and Pain Points - Elderly consumers have diverse needs that go beyond basic nutrition, including specific dietary requirements for chronic diseases and preferences for taste and texture [11][12]. - Common health issues among the elderly include digestive problems, nutrient deficiencies, and a high prevalence of chronic diseases such as hypertension and diabetes [10][11]. - The market faces significant challenges, including product homogenization, lack of standardized regulations, and misleading marketing practices targeting elderly consumers [17][19]. Group 3: Product and Service Trends - There is a growing demand for high-quality, specialized products that cater to the unique nutritional needs of the elderly, including functional foods and easy-to-chew options [15][19]. - The trend towards online shopping is increasing among elderly consumers, who are becoming more familiar with digital purchasing platforms [16]. - Innovations in product formulation and packaging are emerging, focusing on enhancing the user experience for elderly consumers, such as easy-to-open packages and clear labeling [34][36]. Group 4: Regulatory and Competitive Landscape - The regulatory framework for elderly food products in China is still developing, with recent standards being introduced to improve product safety and quality [36]. - Comparatively, countries like Japan have established a more mature elderly food industry with detailed classifications and standards, serving as a model for China's market development [24][26]. - The competition in the elderly food market is expected to intensify as companies strive to meet the evolving demands of this demographic, emphasizing the need for differentiated products and services [37].
2元和200元的钙片,到底有什么区别?
Zhong Guo Jing Ji Wang· 2025-03-02 00:12
Core Viewpoint - The article discusses the importance of calcium supplementation for preventing osteoporosis and highlights the differences in calcium supplements available in the market, emphasizing the need for informed choices when purchasing them. Group 1: Importance of Calcium - Calcium is a crucial nutrient for human health, involved in bone formation, muscle function, and various cellular processes [1] - The recommended daily calcium intake is 800 mg for adults and pregnant women, and 1000 mg for adolescents aged 9-18 [1] - The median calcium intake in China is only 328.3 mg per day, with a deficiency rate of 94.3%, indicating a significant need for calcium supplementation [1] Group 2: Misconceptions About Calcium Supplements - The effectiveness of calcium supplements does not significantly differ between low-cost and high-cost options, as they contain similar core ingredients [2] - There are three main types of calcium: inorganic calcium (e.g., calcium carbonate), organic calcium (e.g., calcium citrate), and amino acid chelated calcium, each with different absorption characteristics [2] - High calcium content in supplements does not guarantee better absorption; excessive intake can lead to adverse health effects [4] Group 3: Dietary Recommendations - A balanced diet rich in dairy products is the best source of calcium, with a recommended daily intake of 300-500 grams of dairy for adults [7] - For individuals with normal digestive function, calcium carbonate is recommended due to its high calcium content and good absorption rate [8] - It is advised to limit calcium intake to no more than 500 mg at a time for optimal absorption, and to consult healthcare professionals for higher needs [9] Group 4: Role of Vitamin D - Vitamin D is essential for calcium absorption, and taking both together can help reduce the risk of osteoporosis [10]